| IPI00021792 - PLA2G1B, PHOSPHOLIPASE A2 PRECURSOR. | |
|---|---|
| Uniprot Accession: P04054 | |
| Uniprot ID: PA21B_HUMAN | |
| Mapping: Chr 12, 119244298 - 119249975 | |
| Entrez Gene: 5319 | |
| Entrez MapView: |
|
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_11097) |
|---|
| Rat: Pla2g1b, PHOSPHOLIPASE A2 PRECURSOR. |
| Mouse: Pla2g1b, PHOSPHOLIPASE A2 PRECURSOR. |
| Mouse: Pla2g1b, 9 KDA PROTEIN. |
| Mouse: Pla2g1b, 14 KDA PROTEIN. |
| Human: PLA2G1B, PHOSPHOLIPASE A2 PRECURSOR. |
| Human: PLA2G1B, PLA2G1B PROTEIN. |
| Human: PLA2G1B, 13 KDA PROTEIN. |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| extracellular region | C | IDA TAS | ISS | |
| extracellular space | C | RCA | ISS | |
| hydrolase activity | F | IEA | IEA | IEA |
| receptor binding | F | IEA | IDA | IEA ISS |
| calcium ion binding | F | IEA | IEA IEA | IEA |
| metal ion binding | F | IEA | ||
| phospholipase A2 activity | F | TAS IEA | IDA | IEA ISS ISS |
| signal transduction | P | TAS | ISS | |
| phospholipid catabolic process | P | TAS | ISS | |
| cell proliferation | P | TAS | ISS | |
| phospholipid metabolic process | P | IEA | IEA | IEA |
| response to stress | P | TAS | ISS | |
| lipid catabolic process | P | IEA | IEA IEA | IEA |
| actin filament organization | P | TAS | ISS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| adipose tissue phenotype | MP | Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| growth/size phenotype | MP | Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| liver/biliary system phenotype | MP | Un | ||
| decreased circulating insulin level | N | ISS | ||
| decreased circulating leptin level | N | ISS | ||
| resistance to diet-induced obesity | N | ISS | ||
| decreased circulating triglyceride level | N | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| glycerolipid metabolic pathway | W | IEA | ||
| eicosanoids metabolic pathway | W | IEA | ||
| mitogen activated protein kinase signaling pathway | W | IEA | ||
| phospholipid metabolic pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| GnRH signaling pathway (04912) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Long-term depression (04730) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Glycerophospholipid metabolism (00564) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Ether lipid metabolism (00565) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Fc epsilon RI signaling pathway (04664) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| MAPK signaling pathway (04010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| VEGF signaling pathway (04370) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Arachidonic acid metabolism (00590) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Linoleic acid metabolism (00591) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |